CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway

American Journal of Physiology - Cell Physiology

Volumn 291, Issue 3, 2006, Pages

  Villa, I ^a   Mrak, E ^a,b   Rubinacci, A ^a   Ravasi, F ^a   Guidobono, F ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Cathepsin K; Osteoclast; Protein kinase A; Receptor activity modifying proteins

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; OSTEOPROTEGERIN;

ARTICLE; DOSE RESPONSE; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

ACID PHOSPHATASE; AGED; BONE REMODELING; CALCITONIN GENE-RELATED PEPTIDE; CARRIER PROTEINS; CATHEPSINS; CELL SEPARATION; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FEMORAL FRACTURES; FORSKOLIN; GLYCOPROTEINS; HUMANS; ISOENZYMES; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; OSTEOBLASTS; OSTEOCLASTS; OSTEOPROTEGERIN; PEPTIDE FRAGMENTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION;

EID: 33748413499     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00354.2005     Document Type: Article

References (49)

1. Akopian A, Demulder A, Ouriaghli F, Corazza F, Fondu P, and Bergmann P. Effects of CGRP on human osteoclast-like cells formation: a possible connection with the bone loss in neurological disorders? Peptides 21: 559-564, 2000.
2. Amara SG, Jones V, Rosenfeld MG, Ong ES, and Evans RM. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 29: 240-249, 1982.
3. Ballica R, Valentijn K, Khachatryan A, Guerder S, Kapadia S, Gundberg C, Gilligan T, Flavell RA, and Vignery A. Targeted expression of calcitonin gene-related peptide to osteoblasts increase bone density in mice. J Bone Miner Res 14: 1067-1074, 1999.
4. Bergh JJ, Xu Y, and Farach-Carson MC. Osteoprotegerin expression and secretion are regulated by calcium influx through the L-type voltage-sensitive calcium channel. Endocrinology 145: 426-436, 2004.
5. 2 in human bone marrow stroma cells. Biochem Biophys Res Commun 247: 338-341, 1998.
6. Burns DM, Stehno-Bittel L, and Kawase T. Calcitonin gene-related peptide elevates calcium and polarizes membrane potential in MG-63 cells by both cAMP-independent and -dependent mechanisms. Am J Physiol Cell Physiol 287: C457-C467, 2004.
7. Cheung J, Mak YT, Papaioannou S, Evans BAJ, Fogelman I, and Hampson G. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-β oestradiol and raloxifene. J Endocrinol 177: 423-433, 2003.
8. Cornish J, Callon KE, Bava U, Kamona SA, Cooper GJS, and Reid IR. Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. Bone 29: 162-168, 2001.
9. Cornish J, Callon KE, Lin CQ, Xiao CL, Gamble GD, Cooper GJ, and Reid JR. Comparison of the effects of calcitonin gene-related peptide and amylin on osteoblasts. J Bone Miner Res 14: 1302-1309, 1999.
10. Drissi H, Hott M, Marie PJ, and Lasmoles F. Expression of CT/CGRP gene and its regulation by dibutyryl cyclic adenosine monophosphate in human osteoblastic cells. J Bone Miner Res 12: 1805-1814, 1997.
11. 2+ concentrations but not cyclic AMP formation in CGRP receptor-positive osteosarcoma cells (OHS-4). Cytokine 11: 200-207, 1999.
12. Fu Q, Jilka RL, Manolagas SC, and O'Brien CA. Parathyroid hormone stimulates receptor activator of NFkB ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein. J Biol Chem 277: 48868-48875, 2002.
13. Fujikawa Y, Quinn JMW, Sabokbar A, McGee JO, and Athanasou NA. The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 137: 4058-4060, 1996.
14. Gehron Robey P and Termine JD. Human bone cells in vitro. Calcif Tissue Int 37: 453-460, 1985.
15. Hilairet S, Belanger C, Bertrand J, Laperrière A, Foord SM, and Bouvier M. Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1) and β-arrestin. J Biol Chem 276: 42182-42190, 2001.
16. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, and Riggs BL. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15: 2-12, 2000.
17. Huang JC, Sakata T, Pfleger LL, Bencsik M, Halloran BP, Bikle DD, and Nissenson RA. PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res 19: 235-244, 2004.
18. Hukkanen M, Konttinen YT, Santavirta S, Paavolainen P, Gu XH, Terenghi G, and Polak JM. Rapid proliferation of calcitonin gene-related peptide-immunoreactive nerves during of rat healing fracture suggests neural involvement in bone growth and remodeling. Neuroscience 54: 969-979, 1993.
19. Imai S, Rauvala H, Konttinen YT, Tokunaga T, Maeda T, Hukuda S, and Santavirta S. Efferent targets of osseues CGRP-immunoreactive nerve fiber before and after bone destruction in adjuvant arthritic rat: an ultramorphological study on their terminal-target relations. J Bone Miner Res 12: 1018-1027, 1997.
20. Irie K, Hara-Irie F, Ozawa H, and Yajima T. Calcitonin gene-related peptide (CGRP)-containing nerve fibers in bone tissue and their involvement in bone remodeling. Microsc Res Tech 58: 85-90, 2002.
21. Ishizuka K, Hirukawa K, Nakamura H, and Togari A. Inhibitory effect of CGRP on osteoclast formation by mouse bone marrow cells treated with isoproterenol. Neurosci Lett 379: 47-51, 2005.
22. Kawase T and Burns DM. Calcitonin gene-related peptide stimulates potassium efflux through adenosine triphosphate-sensitive potassium channels and produces membrane hyperpolarization in osteoblastic UMR106 cells. Endocrinology 139: 3492-3502, 1998.
23. Koller D, Ittner LM, Muff R, Husmann K, Fischer JA, and Born W. Selective inactivation of adrenomedullin over calcitonin gene-related peptide receptor function by the deletion of amino acids 14-20 of the mouse calcitonin-like receptor. J Biol Chem 279: 20387-20391, 2004.
24. Kondo H, Guo J, and Bringhurst FR. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormonerelated protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. J Bone Miner Res 17: 1667-1679, 2002.
25. Lacey DL, Timms E, Tan HL, Kelly MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, and Boyle WJ. Osteoprotegerin (OPG) ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 3597-3602, 1998.
26. Lee SK and Lorenzo JA. Regulation of receptor activator of nuclear factor-κB ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase A pathway in murine bone marrow cultures. Bone 31: 252-259, 2002.
27. Li X, Okada Y, Pilbeam CC, Lorenzo JA, Kennedy CR, Breyer RM, and Raisz LG. Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro. Endocrinology 141: 2054-2061, 2000.
28. Lian K, Du J, Rao Z, and Luo H. The experimental study on the effect of calcitonin gene-related peptide on bone resorption mediated by interleukin-1. J Tongji Med Univ 21: 304-307, 2001.
29. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, and Foord SM. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393: 333-339, 1998.
30. Michelangeli VP, Fletcher AE, Allan EH, Nicholson GC, and Martin TJ. Effects of calcitonin gene-related peptide on cyclic AMP formation in chicken, rat and mouse bone cells. J Bone Miner Res 4: 269-272, 1989.
31. Millet I and Vignery A. The neuropeptide calcitonin gene-related peptide inhibits TNF-α but poorly induces IL-6 production by fetal rat osteoblast. Cytokine 9: 999-1007, 1997.
32. Minkin C. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 34: 285-290, 1982.
33. Mundy GR, Chen D, and Oyajobi O. Bone remodeling. In: Primer of Bone Metabolic Disorders of Mineral Metabolism, edited by Favus MJ. New York: Am Soc Bone Mineral Res, 2003.
34. Nakamura M, Udagawa N, Matsuura S, Mogi M, Nakamura H, Horiuchi H, Saito N, Hiraoka Y, Kobayashi Y, Takaoka K, Ozawa AH, Miyazawa H, and Takahashi N. Osteoprotegerin regulate bone formation through a coupling mechanism with bone resorption. Endocrinology 144: 5441-5449, 2003.
35. Naot D, Callon KE, Grey A, Cooper GJS, Reid IR, and Cornish J. A potential role for adrenomedullin as a local regulator of bone growth. Endocrinology 142: 1849-1857, 2001.
36. Onuoha GN. Circulating sensory peptide levels within 24h of human bone fracture. Peptides 22: 1107-1110, 2001.
37. Paralkar VM, Borovecki F, Ke HZ, Cameron KO, Lefker B, Grasser WA, Owen TA, Li M, Da Silva-Jardine P, Zhou M, Dunn RL, Dumont F, Korsmeyer R, Krasney P, Brown TA, Plowchalk D, Vukicevic S, and Thomsson DD. An EP2 receptor-selective prostaglandin induces bone healing. Proc Natl Acad Sci USA 100: 6736-6740, 2003.
38. Schinke T, Liese S, Priemel M, Haberland M, Schilling AF, Catala-Lehnen P, Blicharski D, Rueger JM, Gagel RF, Emeson RB, and Amling M. Decreased bone formation and osteopenia in mice lacking α-calcitonin gene-related peptide. Neuropeptides 38: 111-112, 2004.
39. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, and Boyle WJ. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89: 309-319, 1997.
40. 2 is crucially involved in lipopolysaccharide-induced osteoclast formation. J Immunol 172: 2504-2510, 2004.
41. Taranta A, Fortunati D, Longo M, Rucci N, Iacomino E, Facciuto E, Migliaccio S, Bardella MT, Dubini A, Borghi MO, Saraifoger S, Teti A, and Bianchi ML. Imbalance of osteoclastogenesis-regulating factors in patients with celiac disease. J Bone Miner Res 19: 1112-1121, 2004.
42. Theoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, and Heymann D. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev 15: 457-475, 2004.
43. Tsujiawa T, Inoue H, and Nishihara T. SC-19220, antagonist of prostaglandin E2 receptor EP1, inhibits osteoclastogenesis by RANKL. J Bone Miner Res 20: 15-22, 2005.
44. Valentijn K, Gutow AP, Troiano N, Gundberg C, Gilligan JP, and Vignery A. Effects of calcitonin gene-related peptide on bone turnover in ovariectomized rats. Bone 21: 269-274, 1997.
45. Vignery A and McCarthy TL. The neuropeptide calcitonin gene-related peptide stimulates insulin-like growth factor I production by primary fetal rat osteoblasts. Bone 18: 331-335, 1996.
46. Villa I, Dal Fiume C, Maestroni A, Rubinacci A, Ravasi F, and Guidobono F. Human osteoblast-like cell proliferation induced by calcitonin-related peptides involves PKC activity. Am J Physiol Endocrinol Metab 284: E627-E633, 2003.
47. Villa I, Melzi R, Pagani F, Ravasi F, Rubinacci A, and Guidobono F. Effects of calcitonin gene-related peptide and amylin on human osteoblast-like cells proliferation. Eur J Pharmacol 409: 273-278, 2000.
48. Yasuda H, Shima N, Nakagawa N, Mochizuki SI, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, and Higashio K. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 39: 1329-1337, 1998.
49. Zaidi M, Chamber TJ, Gaines RE, Morris HR, and McIntyre I. A direct activity of human calcitonin gene related peptide on isolated osteoclasts. J Endocrinol 115: 511-518, 1987.